Reshma Ramachandran

@reshmagar.bsky.social

1168 Followers 525 Following

Assistant Professor, primary care physician, and health services researcher at Yale School of Medicine, Co-Director of the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT); *views expressed here are my own*

(v) the Commissioner of Food and Drugs shall review and potentially modify or revoke approvals granted for drugs, for those drugs that maybe be unsafe, ineffective, or improperly marketed; and

Good morning,

The system shows your request was assigned to the Center for Drug Education and Research (CDER) FOIA office for processing. However, the CDER FOIA staff were affected by the April 1, 2025, Reduction in Force (RIF) and as a result CDER FOIA operations are currently suspended. I am therefore unable to provide you with any status updates.

I would recommend checking back in a few weeks.

Sincerely,

C.

and NCHS, NIH, and SAMHSA.

Additional defendants are shown in this screenshot to include AHRQ, CBHSQ, CMS, HRSA,...

This image is a screenshot of an amended complaint filed by Doctors for America and the City and County of San Francisco v Office of Personnel Management, CDC, FDA, HHS, AHRQ,...

Question 10: On October 25th, you tweeted that “FDA’s war on public health is about to end”
and that “If you work for the FDA and are part of this corrupt system, I have two messages for
you: 1) Preserve your records, and 2) Pack your bags.” If a career staffer engaged in scientific
decision-making that disagrees with your views or the President’s, will you fire them?

Response: If confirmed, I look forward to following the law, including relevant employment
and labor relations laws.

This is a screenshot of the webpage for the FDA Approved Risk Evaluation and Mitigation Strategies (REMS) website that now reads, "The FDA's REMS@FDA website is temporarily unavailable. Approved REMS remain in effect, even while the website is unavailable. Thank you for your patience."